Anterix (ATEX) Asset Writedowns and Impairment (2018 - 2022)

Anterix (ATEX) has 5 years of Asset Writedowns and Impairment data on file, last reported at $127000.0 in Q1 2022.

• Quarterly Asset Writedowns and Impairment rose 182.22% year-over-year to $127000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2021 was -$82000.0 (down 254.72% YoY) and the FY2021 annual result came in at $85000.0, up 84.78% from the prior year.
• Asset Writedowns and Impairment rose to $127000.0 in Q1 2022, from -$254000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $534000.0 in Q2 2018 to a low of -$254000.0 in Q4 2021.
• A 5-year average of $70307.7 and a median of $33000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 246.15% in 2021, down 2409.09% in 2021.
• Tracing ATEX's Asset Writedowns and Impairment over 5 years: stood at $200000.0 in 2018, then sank by 83.5% to $33000.0 in 2019, then slumped by 66.67% to $11000.0 in 2020, then tumbled by 2409.09% to -$254000.0 in 2021, then soared by 150.0% to $127000.0 in 2022.
• The last three Asset Writedowns and Impairment figures came in at $127000.0 (Q1 2022), -$254000.0 (Q4 2021), and $112000.0 (Q3 2021), per Business Quant data.